Logo image of EMO.CA

EMERITA RESOURCES CORP (EMO.CA) Stock Fundamental Analysis

TSX-V:EMO - TSX Venture Exchange - CA29102L4064 - Common Stock - Currency: CAD

1.15  -0.05 (-4.17%)

Fundamental Rating

2

Overall EMO gets a fundamental rating of 2 out of 10. We evaluated EMO against 797 industry peers in the Metals & Mining industry. While EMO seems to be doing ok healthwise, there are quite some concerns on its profitability. EMO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EMO had negative earnings in the past year.
In the past year EMO has reported a negative cash flow from operations.
EMO had negative earnings in each of the past 5 years.
EMO had a negative operating cash flow in each of the past 5 years.
EMO.CA Yearly Net Income VS EBIT VS OCF VS FCFEMO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

With a Return On Assets value of -98.45%, EMO is not doing good in the industry: 75.03% of the companies in the same industry are doing better.
EMO has a worse Return On Equity (-249.59%) than 74.03% of its industry peers.
Industry RankSector Rank
ROA -98.45%
ROE -249.59%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMO.CA Yearly ROA, ROE, ROICEMO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EMO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMO.CA Yearly Profit, Operating, Gross MarginsEMO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for EMO has been increased compared to 5 years ago.
EMO.CA Yearly Shares OutstandingEMO.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2024 50M 100M 150M 200M
EMO.CA Yearly Total Debt VS Total AssetsEMO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 15.49 indicates that EMO is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 15.49, EMO is doing good in the industry, outperforming 76.54% of the companies in the same industry.
A Debt/Equity ratio of 1.09 is on the high side and indicates that EMO has dependencies on debt financing.
The Debt to Equity ratio of EMO (1.09) is worse than 75.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Altman-Z 15.49
ROIC/WACCN/A
WACCN/A
EMO.CA Yearly LT Debt VS Equity VS FCFEMO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 5.42 indicates that EMO has no problem at all paying its short term obligations.
EMO has a Current ratio of 5.42. This is in the better half of the industry: EMO outperforms 76.41% of its industry peers.
A Quick Ratio of 5.42 indicates that EMO has no problem at all paying its short term obligations.
EMO's Quick ratio of 5.42 is fine compared to the rest of the industry. EMO outperforms 76.66% of its industry peers.
Industry RankSector Rank
Current Ratio 5.42
Quick Ratio 5.42
EMO.CA Yearly Current Assets VS Current LiabilitesEMO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.23% over the past year.
EPS 1Y (TTM)30.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.04%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

EMO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 90.42% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5Y90.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMO.CA Yearly Revenue VS EstimatesEMO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 200M 400M 600M 800M
EMO.CA Yearly EPS VS EstimatesEMO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2028 2029 0.2 0.4 0.6 0.8 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EMO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMO.CA Price Earnings VS Forward Price EarningsEMO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMO.CA Per share dataEMO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04

4.3 Compensation for Growth

A more expensive valuation may be justified as EMO's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

EMO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMERITA RESOURCES CORP

TSX-V:EMO (8/8/2025, 7:00:00 PM)

1.15

-0.05 (-4.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)01-27 2022-01-27
Inst Owners1.12%
Inst Owner ChangeN/A
Ins Owners5.5%
Ins Owner ChangeN/A
Market Cap303.82M
Analysts86.67
Price Target3.21 (179.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 57.67
P/tB 57.67
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -98.45%
ROE -249.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2796.72%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.42
Quick Ratio 5.42
Altman-Z 15.49
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)855.19%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-65.04%
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5Y90.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.39%
OCF growth 3YN/A
OCF growth 5YN/A